AI-generated · cited to primary sources · not investment advice
Sagility (544282) Oct 2025 Filing Analysis
Does management do what it says?
The company is actively pursuing cross-selling opportunities following the BroadPath acquisition, with several deals in discussion. — target: At least a dozen opportunities (+3 more commitments)
“16.0% Y-o-Y organic growth in Q2 FY26 driven by expansion from existing clients, while new wins are expected to further strengthen momentum in H2”
Management is shifting deal constructs toward Per-Member-Per-Month (PMPM) models to de-risk payers and provide outcome-based pricing.
“Commercial construct in such models is “per-member-per-month (PMPM)” which will de-risk the payer vs traditional billing models like Transaction Rate or FTE rate.”
See the full cited Management analysis of Sagility
How durable is the business?
Sagility is shifting its deal constructs from labor-based (FTE) to technology-led models like Per-Member-Per-Month (PMPM) and AI-agent pricing, which is roughly 10-35% of human cost. (2 shifted, 1 expanding)
“The deal construct here is, no more the traditional FTE or transaction rate, but it's more of a per-member-per-month or what we call PMPM... the AI agents, will also be charged at a different rate. And that rate will be a fraction of the cost, that we charge for a human process transaction.”
See the full cited Business Model analysis of Sagility
Where does growth come from?
The company is pivoting toward complex AI-driven 'Transform-in-place' solutions to help clients manage cost pressures, targeting 20-40% savings through GenAI. (1 new trend across 1 signal)
“Sagility has proposed a GenAI-powered, cloud-based engagement solution to achieve 25-40% savings... deployed 25 AI based use-cases”
See the full cited Future Growth analysis of Sagility
What could break the thesis?
The risk is easing as these investments are now translating into higher EBITDA margins (26.2%) and improved delivery efficiency. (2 easing, 1 stable)
“we have consolidated some sites, which has actually helped us in an optimising operational cost.”
See the full cited Risk analysis of Sagility
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.